Swiss National Bank’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-254,000
| Closed | -$1.53M | – | 2499 |
|
|
2019
Q4 | $1.53M | Buy |
254,000
+8,900
| +4% | +$51.5K | ﹤0.01% | 1878 |
|
|
2019
Q3 | $882K | Hold |
245,100
| – | – | ﹤0.01% | 2117 |
|
|
2019
Q2 | $657K | Buy |
245,100
+43,000
| +21% | +$127K | ﹤0.01% | 2327 |
|
|
2019
Q1 | $598K | Buy |
202,100
+12,300
| +6% | +$30.2K | ﹤0.01% | 2310 |
|
|
2018
Q4 | $302K | Hold |
189,800
| – | – | ﹤0.01% | 2472 |
|
|
2018
Q3 | $698K | Hold |
189,800
| – | – | ﹤0.01% | 2314 |
|
|
2018
Q2 | $537K | Hold |
189,800
| – | – | ﹤0.01% | 2427 |
|
|
2018
Q1 | $704K | Hold |
189,800
| – | – | ﹤0.01% | 2277 |
|
|
2017
Q4 | $547K | Buy |
189,800
+30,400
| +19% | +$110K | ﹤0.01% | 2385 |
|
|
2017
Q3 | $716K | Hold |
159,400
| – | – | ﹤0.01% | 2239 |
|
|
2017
Q2 | $732K | Sell |
159,400
-23,000
| -13% | -$92.4K | ﹤0.01% | 2243 |
|
|
2017
Q1 | $768K | Hold |
182,400
| – | – | ﹤0.01% | 2187 |
|
|
2016
Q4 | $753K | Hold |
182,400
| – | – | ﹤0.01% | 2206 |
|
|
2016
Q3 | $1.48M | Sell |
182,400
-6,700
| -4% | -$57K | ﹤0.01% | 1714 |
|
|
2016
Q2 | $1.48M | Buy |
189,100
+3,600
| +2% | +$30.9K | ﹤0.01% | 1721 |
|
|
2016
Q1 | $1.39M | Buy |
185,500
+33,100
| +22% | +$242K | ﹤0.01% | 1695 |
|
|
2015
Q4 | $1.64M | Buy |
152,400
+9,700
| +7% | +$88.2K | ﹤0.01% | 1471 |
|
|
2015
Q3 | $986K | Buy |
142,700
+20,700
| +17% | +$169K | ﹤0.01% | 1789 |
|
|
2015
Q2 | $1.08M | Buy |
122,000
+18,800
| +18% | +$178K | ﹤0.01% | 1746 |
|
|
2015
Q1 | $1.02M | Buy |
103,200
+22,900
| +29% | +$286K | ﹤0.01% | 1757 |
|
|
2014
Q4 | $984K | Buy |
80,300
+2,100
| +3% | +$25.6K | ﹤0.01% | 1738 |
|
|
2014
Q3 | $780K | Sell |
78,200
-2,400
| -3% | -$22.3K | ﹤0.01% | 1813 |
|
|
2014
Q2 | $610K | Hold |
80,600
| – | – | ﹤0.01% | 2057 |
|
|
2014
Q1 | $265K | Buy |
80,600
+15,200
| +23% | +$53.2K | ﹤0.01% | 2369 |
|
|
2013
Q4 | $217K | Hold |
65,400
| – | – | ﹤0.01% | 2374 |
|
|
2013
Q3 | $198K | Sell |
65,400
-3,500
| -5% | -$24K | ﹤0.01% | 2360 |
|
|
2013
Q2 | $564K | Buy |
+68,900
| New | +$526K | ﹤0.01% | 1833 |
|
Swiss National Bank's ACHN Position: Q1 2020 in Review
Swiss National Bank sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 254,000 shares — an estimated $1.53M sold.
Swiss National Bank first reported a position in ACHN in Q2 2013 and held it in 27 quarters. The position peaked at $1.64M in Q4 2015. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- Swiss National Bank reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- Swiss National Bank sold 254,000 Achillion Pharmaceuticals shares in Q1 2020, an estimated $1.53M.
- Swiss National Bank first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 27 quarters.
- Swiss National Bank's Achillion Pharmaceuticals position peaked at $1.64M in Q4 2015.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on Swiss National Bank's 13F filing for Q1 2020, filed 8 May 2020.